⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12463717 | 1.00 | — | — | |
| SCHEMBL12329241 | 1.00 | — | — | |
| SCHEMBL260181 | 1.00 | — | — | |
| SCHEMBL18523022 | 0.92 | GBA1 (0.41) | — | |
| SCHEMBL18707465 | 0.92 | GBA1 (0.41) | — | |
| SCHEMBL18962605 | 0.92 | GBA1 (0.41) | — | |
| SCHEMBL16785937 | 0.92 | GBA1 (0.41) | — | |
| SCHEMBL22631740 | 0.92 | GBA1 (0.41) | — | |
| SCHEMBL21783260 | 0.92 | GBA1 (0.41) | — | |
| SCHEMBL13425150 | 0.92 | GBA1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8389565-B2 | Antidiabetic agents; controlling carbohydrate metabolism | SIMON FRASER UNIVERSITY (CA) | 2013-03-05 | — | — | US | disclosed |
| US-20110237538-A1 | TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DISEASES | SUMMIT CORPORATION PLC (GB) | 2011-09-29 | — | — | US | disclosed |
| US-20110195929-A1 | COMPOUNDS FOR THE TREATMENT OF FLAVIVIRAL INFECTIONS | SUMMIT CORPORATION PLC (GB) | 2011-08-11 | — | — | US | disclosed |